ReviewCureus2025
Short- and Long-Term Pain Relief With Radiofrequency Rhizotomy in Multiple Sclerosis Patients With Trigeminal Neuralgia: A Systematic Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Trigeminal neuralgia (TN) in patients with multiple sclerosis (MS) is a debilitating condition that is often refractory to medical management. Radiofrequency rhizotomy (RFR) is a commonly used percutaneous intervention, but its outcomes in this specific population require a comprehensive synthesis. This systematic review aims to evaluate the short- and long-term pain relief, recurrence rates, and safety profile of RFR in patients with MS-associated TN (MS-TN). A systematic search of PubMed, Scopus, Web of Science, and Embase was performed up to October 2025. Eight studies meeting the inclusion criteria, all of retrospective design, were selected. Data on study characteristics, pain relief outcomes, recurrence, complications, and repeat procedures were extracted. The risk of bias was assessed using the ROBINS-I tool. The analysis of the included studies demonstrated that RFR provides high rates of short-term pain relief, with a significant majority of patients achieving favorable outcomes soon after the procedure. However, the long-term durability of pain relief was variable, showing a declining trend over time, with pain recurrence being a common feature. This pattern often necessitated repeated procedures to maintain pain control. The most frequently reported complications were facial sensory disturbances, which were generally well-tolerated, while major adverse events were rare. The methodological quality of the evidence was predominantly low risk of bias. RFR is a highly effective intervention for achieving rapid short-term pain relief in MS-TN, making it a valuable option for managing acute exacerbations. Its long-term utility is defined by its repeatability, as pain recurrence is common, necessitating a chronic disease management strategy. The procedure's favorable risk-benefit profile and procedural flexibility solidify its role as a cornerstone in the multimodal treatment arsenal for this challenging condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.